Does ashwagandha (Withania somnifera) interact with vitamin D, vitamin B12, or fish oil supplements?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No Clinically Significant Interactions Between Ashwagandha and Vitamin D, B12, or Fish Oil

Based on available evidence, ashwagandha does not have documented clinically significant interactions with vitamin D, vitamin B12, or fish oil supplements, and these can be safely taken together.

Evidence Assessment

Direct Interaction Data

The provided evidence contains no guidelines or research specifically documenting interactions between ashwagandha (Withania somnifera) and vitamin D, B12, or fish oil. The most relevant safety data comes from recent clinical trials and pharmacological studies:

Ashwagandha's Drug Metabolism Profile:

  • Recent research shows ashwagandha root extracts modulate CYP3A4 enzyme expression 1, which is a major drug-metabolizing enzyme
  • However, comprehensive safety reviews found no in vitro or in vivo inhibition of CYP3A4 or CYP2D6 2, the two major hepatic drug metabolizing enzymes
  • This suggests minimal potential for metabolic interactions with supplements

Clinical Safety Evidence:

  • A 180-day randomized controlled trial in healthy adults (200 mg twice daily) showed ashwagandha was well-tolerated with no adverse effects on hematological, hepatic, renal, or lipid profiles 3
  • Multiple human studies (30 clinical trials reviewed) reported only mild, transient adverse events (somnolence, GI discomfort) with no serious events 2
  • No documented interactions with common supplements emerged from these trials

Individual Supplement Considerations

Fish Oil:

  • The guidelines extensively discuss fish oil's safety profile, noting theoretical bleeding concerns but a large placebo-controlled trial found no increase in perioperative bleeding 4
  • Fish oil has no documented interactions with herbal supplements in the provided evidence
  • Both ashwagandha and fish oil have been studied independently without reports of combined use complications

Vitamin B12:

  • Guidelines recommend B12 supplementation post-bariatric surgery and with certain medications (PPIs, metformin) 5, 6
  • No evidence suggests ashwagandha affects B12 absorption or metabolism
  • B12 is water-soluble with minimal interaction potential with herbal adaptogens

Vitamin D:

  • Extensively studied in cardiovascular and bone health contexts 7, 8
  • No documented interactions with herbal supplements in the evidence
  • Fat-soluble vitamin with well-characterized absorption pathways unlikely to be affected by ashwagandha

Clinical Recommendations

You can confidently advise patients to take these supplements together with the following considerations:

  • Timing: No specific separation needed between doses
  • Monitoring: Standard monitoring for each supplement individually (B12 levels if indicated, vitamin D levels for bone health, etc.)
  • Quality concerns: Ensure ashwagandha products are from reputable manufacturers, as dietary supplements lack FDA standardization 2, 9

Important Caveats

Watch for these scenarios:

  • Patients on anticoagulants: While fish oil showed no bleeding increase in trials 4, theoretical concerns exist—monitor INR if on warfarin
  • Thyroid medication users: Ashwagandha may increase T4 levels 2—monitor thyroid function
  • Sedative users: Ashwagandha has mild CNS depressant effects 2—may potentiate sedation
  • Pregnancy: Avoid ashwagandha due to insufficient safety data 9

The absence of documented interactions across multiple clinical trials and safety reviews, combined with ashwagandha's lack of significant CYP enzyme inhibition, supports the safety of concurrent use with these common nutritional supplements.

References

Guideline

use of dietary supplements in living kidney donors: a critical review.

American Journal of Kidney Diseases, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.